Safety and Immunogenicity of a candidate MERS-CoV Viral Vectored Vaccine: a phase I, open-labelled, first-in-human, dose-escalation trial.
2020
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI